[Intraocular penetration of 7 drugs with therapeutic effect on toxoplasmosis].
Tassignon
M J
MJ
Brihaye
M
M
De Meuter
F
F
Vercruysse
A
A
Van Hoff
F
F
Merckaert
I
I
D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D001813:Blood-Retinal Barrier; D004318:Doxycycline / Q000493:pharmacokinetics; D005260:Female; D008297:Male; D010118:Oxytetracycline / Q000493:pharmacokinetics; D011817:Rabbits; D015572:Spiramycin / Q000493:pharmacokinetics; D013420:Sulfamethoxazole / Q000493:pharmacokinetics; D013752:Tetracycline / Q000493:pharmacokinetics; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy*; D014295:Trimethoprim / Q000493:pharmacokinetics; D014217:Troleandomycin / Q000493:pharmacokinetics
D000981:Antiprotozoal Agents; D015572:Spiramycin; D014295:Trimethoprim; D014217:Troleandomycin; D013752:Tetracycline; D013420:Sulfamethoxazole; D004318:Doxycycline; D010118:Oxytetracycline
Etude de la pénétration intraoculaire de sept drogues ayant un effet thérapeutique sur le toxoplasme.